October 1 - 4, 2017
Boston Marriott Copley Hotel
Abstract submission deadline: Friday, July 14
Advance registration deadline: Friday, September 8
October 1-4, 2017Boston Marriott Copley PlaceBoston, Massachusetts
Advance Registration Deadline: Friday, September 8, 2017, 11:59 p.m. ET
Conference CochairsJames P. Allison, The University of Texas MD Anderson Cancer Center, Houston, TexasCarl H. June, University of Pennsylvania, Philadelphia, PennsylvaniaMiriam Merad, Icahn School of Medicine at Mount Sinai, New York, New YorkGiorgio Trinchieri, National Cancer Institute, Bethesda, Maryland
The AACR Special Conference on Tumor Immunology and Immunotherapy will focus on recent advances in understanding the range of immune responses towards cancer and how these can be modified and harnessed for prevention and therapeutics. This year’s program will focus on mechanisms, models, and novel technologies, with talks on basic research and translational implications, all geared towards a deeper understanding of the immunologic science of the cancer cell in order to design better treatments. The conference will feature the world’s premier oncologists who will present their latest research on current immunotherapies, engineered cells, checkpoints, and combinations. In addition, highly acclaimed basic researchers and immunologists will help bridge the gap between the cutting-edge advances that are under way in the lab, such as single-cell analysis, neoantigens, systems and synthetic biology, and their application to clinical practice. Please join us to take part in these interactions and network with investigators in the field of tumor immunology and immunotherapy.